These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8376417)

  • 1. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.
    Hedrick CC; Castellani LW; Warden CH; Puppione DL; Lusis AJ
    J Biol Chem; 1993 Sep; 268(27):20676-82. PubMed ID: 8376417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
    Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
    Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
    J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions.
    Hedrick CC; Castellani LW; Wong H; Lusis AJ
    J Lipid Res; 2001 Apr; 42(4):563-70. PubMed ID: 11290828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.
    Schultz JR; Gong EL; McCall MR; Nichols AV; Clift SM; Rubin EM
    J Biol Chem; 1992 Oct; 267(30):21630-6. PubMed ID: 1400473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.
    Silver DL; Jiang XC; Tall AR
    J Biol Chem; 1999 Feb; 274(7):4140-6. PubMed ID: 9933608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting in vivo effects of murine and human apolipoprotein A-II. Role of monomer versus dimer.
    Gong EL; Stoltfus LJ; Brion CM; Murugesh D; Rubin EM
    J Biol Chem; 1996 Mar; 271(11):5984-7. PubMed ID: 8626380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.
    Warden CH; Hedrick CC; Qiao JH; Castellani LW; Lusis AJ
    Science; 1993 Jul; 261(5120):469-72. PubMed ID: 8332912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of HDL deficiency in mice overexpressing human apoA-II.
    Julve J; Escolà-Gil JC; Ribas V; González-Sastre F; Ordóñez-Llanos J; Sánchez-Quesada JL; Blanco-Vaca F
    J Lipid Res; 2002 Oct; 43(10):1734-42. PubMed ID: 12364558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
    Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
    J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.
    Walsh A; Ito Y; Breslow JL
    J Biol Chem; 1989 Apr; 264(11):6488-94. PubMed ID: 2495286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome.
    Gordon SM; Li H; Zhu X; Tso P; Reardon CA; Shah AS; Lu LJ; Davidson WS
    J Proteomics; 2016 Sep; 146():184-94. PubMed ID: 27385375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice.
    Chiesa G; Parolini C; Canavesi M; Colombo N; Sirtori CR; Fumagalli R; Franceschini G; Bernini F
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1417-23. PubMed ID: 9743230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
    Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease).
    Alaupovic P; Schaefer EJ; McConathy WJ; Fesmire JD; Brewer HB
    Metabolism; 1981 Aug; 30(8):805-9. PubMed ID: 6790903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the distribution and composition of plasma high density lipoproteins after ingestion of fat.
    Tall AR; Blum CB; Forester GP; Nelson CA
    J Biol Chem; 1982 Jan; 257(1):198-207. PubMed ID: 6796585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I.
    Batal R; Tremblay M; Krimbou L; Mamer O; Davignon J; Genest J; Cohn JS
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):655-64. PubMed ID: 9555873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.